November 30, 2016 Industry warns of Brexit uncertainty for thousands of medicines British patients could lose access to vital medicines unless arrangements are put in place to ensure a seamless licensing system after Britain leaves the European Union, a top industry official said on Wednesday.
November 29, 2016 Injections, implants tested as new weapons to prevent HIV Scientists are taking the battle to prevent HIV to the next level with large-scale trials set to start using injections to protect vulnerable groups such as gay men and women in Africa for at least two months.
November 21, 2016 More than 18 million on HIV treatment, a million more than 2015: UNAIDS LONDON, Nov 21 - More than 18 million people now have access to life-saving AIDS treatment, 1.2 million more than at the end of last year, the United Nations said on Monday.
November 21, 2016 GlaxoSmithKline seeks US approval for triple lung drug GlaxoSmithKline said on Monday it had filed its new three-in-one inhaled lung drug for U.S. approval, putting it on track to reach the market ahead of rivals in 2017, assuming it wins a green light.
November 17, 2016 Some respiratory infections may not need antibiotics Some patients with bacterial respiratory infections may be able to skip antibiotics, a recent study suggests.
November 16, 2016 New drug capsule delivers medicine for weeks after swallowing Scientists have developed a new drug capsule that stays in the stomach for up to two weeks after being swallowed, gradually releasing its payload.
November 16, 2016 Generic heart failure drug costs too high for many uninsured: study The cost of generic drugs that treat heart failure can vary so wildly, even among pharmacies within one area, that uninsured patients may not be able to afford them, according to research reported at the American Heart Association medical meeting in New Orleans on Tuesday.
November 14, 2016 Blood pressure, cholesterol drugs fail to slow cognitive decline: study Taking medicines to lower blood pressure and cholesterol failed to prevent cognitive and functional declines in older adults with moderate risk of heart disease, according to results of a clinical trial presented on Sunday.
November 14, 2016 Drugmakers improve access for poor, GSK ranked top The world's top drugmakers have improved access to medicines in developing countries but still need to do more to make a wider range of products affordable, according to a report on Monday.
November 14, 2016 Pfizer's Celebrex shown to be as safe as ibuprofen or naproxen: study Pfizer Inc's Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and naproxen, and does not appear to cause heart problems that spurred the withdrawal of rival Vioxx, according to a large 10-year study presented on Sunday.
